Koduvally Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 14.35 Cr
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.00 Cr
- Revenue Growth -30.45%
- Profit Growth 28.53%
- Ebitda -33.07%
- Net Worth -2.35%
- Total Assets -2.02%
About Koduvally Institute Of Medical Sciences
Koduvally Institute Of Medical Sciences Private Limited (KIOMSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2010 and has a history of 14 years and ten months. Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 14.35 Cr.
The company has closed loans amounting to ₹5.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Roshik Mannathal, Shabeer Vayoli, Faisalkarattu, and Fourteen other members serve as directors at the Company.
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110KL2010PTC025865
- Company No.
025865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
What products or services does Koduvally Institute Of Medical Sciences Private Limited offer?
Koduvally Institute Of Medical Sciences Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Medical Consultants & Clinics, Dermatology Treatment Services.
Who are the key members and board of directors at Koduvally Institute Of Medical Sciences?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abdul Razack ![]() | Managing Director | 20-Apr-2010 | Current |
Board Members (16)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shameerali Meppoyil ![]() | Director | 25-Jan-2019 | Current |
Roshik Mannathal ![]() | Whole-Time Director | 20-Apr-2010 | Current |
Shabeer Vayoli ![]() | Director | 31-Oct-2023 | Current |
Faisalkarattu ![]() | Whole-Time Director | 20-Apr-2010 | Current |
Faisal Mullampalath ![]() | Whole-Time Director | 20-Apr-2010 | Current |
Abdul Sukkoor ![]() | Whole-Time Director | 20-Apr-2010 | Current |
Financial Performance of Koduvally Institute Of Medical Sciences.
Koduvally Institute Of Medical Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.45% decrease. The company also saw a substantial improvement in profitability, with a 28.53% increase in profit. The company's net worth dipped by a decrease of 2.35%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Koduvally Institute Of Medical Sciences?
In 2023, Koduvally Institute Of Medical Sciences had a promoter holding of 25.76% and a public holding of 74.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹5.00 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 5.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Mar 2012 | Canara Bank | ₹5.00 Cr | Satisfied |
How Many Employees Work at Koduvally Institute Of Medical Sciences?
Koduvally Institute Of Medical Sciences has a workforce of 17 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Koduvally Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koduvally Institute Of Medical Sciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.